Bg pattern

COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Colfinair 2 million UIpowder for solution for inhalation by nebulizer

colistimethate sodium

Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

  1. What is Colfinair and what is it used for
  2. What you need to know before you use Colfinair
  3. How to use Colfinair
  4. Possible side effects
  5. Storage of Colfinair
  6. Contents of the pack and further information

1. What is Colfinair and what is it used for

Antibiotics are used to treat bacterial infections and are not effective against viral infections.

It is essential that you follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not dispose of medications through the drain or in the trash.

Colfinair is administered by inhalation to treat chronic respiratory infections in patients with cystic fibrosis. Colfinair is used when these infections are caused by a specific bacterium called Pseudomonas aeruginosa.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Colfinair

Do not use Colfinair

  • If you are allergic (hypersensitive) to colistimethate sodium, colistin, or other polymyxins.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to use Colfinair:

  • If you have or have had kidney problems
  • If you have myasthenia gravis
  • If you have porphyria
  • If you have asthma.

In premature infants and newborns, caution should be exercised when using Colfinair because the kidneys are not yet fully developed.

Coughing and chest tightness may lead to interruption. This can be alleviated with the use of an inhaled bronchodilator (e.g., salbutamol) before using Colfinair. Your doctor will supervise your first dose of Colfinair and check your lung function before and after administration.

If, despite using a bronchodilator, you experience chest tightness, inform your doctor because this may indicate an allergic reaction and treatment should be discontinued.

During treatment with Colfinair, neurotoxicity may occur with possible dizziness, confusion, or visual disturbances. If you experience side effects such as dizziness, confusion, or visual disturbances, or any not mentioned in this leaflet, inform your doctor.

Taking Colfinair with other medicines

  • medicines that may affect how your kidneys work. Taking these medicines at the same time as Colfinair may increase the risk of kidney damage
  • medicines that may affect the nervous system. Taking these medicines at the same time as Colfinair may increase the risk of side effects on your nervous system
  • medicines called muscle relaxants, often used during general anesthesia. Colfinair may increase the effects of these medicines. If you are going to be given a general anesthetic, inform your anesthesiologist that you are using Colfinair.

If you have myasthenia gravis and are also taking other antibiotics called macrolides (such as azithromycin, clarithromycin, or erythromycin), or antibiotics called fluoroquinolones (such as ofloxacin, norfloxacin, and ciprofloxacin), taking Colfinair increases the risk of muscle weakness and respiratory difficulties even more.

Receiving colistimethate sodium by infusion at the same time as receiving Colfinair by inhalation may increase your risk of experiencing side effects.

Colfinair must not be mixed with any other medicine in the nebulizer!

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Colfinair has a moderate influence on the ability to drive and use machines. During treatment with Colfinair, neurotoxicity may occur with possible dizziness, confusion, or visual disturbances. If you experience any side effects such as dizziness, confusion, or visual disturbances, do not drive or use machines and consult your doctor or pharmacist.

3. How to use Colfinair

Colfinair is for inhalation use only.

Follow the instructions for administration of this medicine exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

The recommended dose is:

Proposed dose

Maximum daily dose

Adults, Adolescents (12 to 17 years), Children (2 to 11 years)

1-2 million units two or three times a day

6 million units

Children under 2 years

0.5-1 million units, twice a day

2 million units

Your doctor may decide to adjust the dose depending on your circumstances. If you are also taking other inhaled medicines, your doctor will tell you in what order to take them.

Note that Colfinair is also available in a vial of 1 million UI, which may be a more suitable dose depending on the dosage prescribed by your doctor.

For use in children under 2 years of age, PARI LC SPRINT Baby (red nozzle adapter) with a mask is recommended.

Your doctor will tell you how long your treatment with Colfinair will last. Do not stop treatment early because when treating bacterial infections, it is essential to complete the full course of treatment to reduce the risk of developing resistance to the infectious bacteria.

Preparation for inhalation treatment

If you are being treated at home, your doctor or nurse will show you how to use Colfinair in your nebulizer when you start this treatment.

To start your treatment, you will need the following:

  • A 10 ml vial of Colfinair 2 million UI
  • 4 ml of sterile NaCl 0.9% solution for inhalation to dissolve the powder
  • A suitable nebulizer for inhalation use of Colfinair (e.g., eFlowrapidor PARI LC SPRINT)

How to prepare Colfinair for inhalation

Before you can introduce Colfinair into the nebulizer and inhale it, it must be dissolved with 3 ml of sterile NaCl 0.9% solution for inhalation. An ampoule contains the correct volume to dissolve Colfinair.

Colfinair must be used immediately after dissolution. Do not dissolve Colfinair until you are ready to administer a dose (see also section 5).

Hands holding a medicine vial and preparing to remove the upper protective cap

Step 1

Take a Colfinair vial and gently tap the glass vial so that the powder settles at the bottom. This ensures that you receive the correct dose of the medication. Open the vial by lifting the upper plastic cap of lavender color.

Medicine bottle with gray cap and hands holding tweezers extracting something from the inside

Step 2

Remove the lavender-colored plastic cap along with the metal ring from the vial.

Glass bottle with cap and a hand holding it while removing the upper protector with an arrow indicating the direction

Step 3

Twist off the lavender-colored cap in the direction of the arrow. Proper completion will allow you to twist off the metal ring. Twist off the metal ring from the side so that the break point on the opposite side bends. Remove the metal ring from the vial. Carefully discard the ring and cap.

Hands holding a vial and a rubber stopper preparing to seal the transparent vial

Step 4

Carefully remove the rubber stopper.

Step 5

  • Add 4 ml of sterile NaCl 0.9% solution for inhalation to Colfinair 2 million UI (lavender cap)
  • Replace the rubber stopper and gently turn the vial twice.
  • Roll the vial gently between your hands to dissolve all visible Colfinair powder at the bottom and side of the vial. Do not shake the vial too hard, as this can cause the solution to foam.
  • Once most of the powder has dissolved, let the vial sit for a few minutes to allow the foam to disappear and the remaining powder to dissolve.

Use Colfinair only when all the powder has dissolved and there are no visible particles in the solution

How to use Colfinair

Colfinair is for inhalation use only with a suitable nebulizer (e.g., eFlowrapidor PARI LC SPRINT).

Read the nebulizer's instructions for use carefully to obtain more information about handling the nebulization system.

It is essential that your nebulization system functions correctly before starting treatment with Colfinair.

Place the components of your nebulizer on a flat, clean surface and follow the manufacturer's instructions for use.

Inhalation should be done in a well-ventilated room.

After inhaling Colfinair

Consult the manufacturer's instructions for use of the nebulizer for cleaning and disinfecting it.

If you use more Colfinair than you should

If you have used more Colfinair than you should, consult your doctor or pharmacist immediately. If too much Colfinair is administered accidentally, the effects can be severe and may include kidney problems, muscle weakness, and respiratory difficulty (even arrest).

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 915 620 420 (indicating the medication and the amount ingested), or go to the nearest hospital.

If you forget to use Colfinair

If you are treating yourself and have forgotten a dose, you should take the forgotten dose as soon as you remember and then the next dose 8 or 12 hours later, and continue from then on as instructed.

Do not take a double dose to make up for forgotten doses.

If you stop using Colfinair

You must not stop using Colfinair as prescribed without consulting your doctor first.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

An allergic reaction may occur. Severe allergic reactions can occur even with the first dose and may include rapid onset of rash, swelling of the face, tongue, and throat, inability to breathe due to narrowing of the airways, and loss of consciousness. Urgent medical attention will be needed.

If you think you have an allergic reaction to Colfinair, inform your doctor immediately.

Some side effects can be serious

Very common: may affect more than 1 in 10 people.

  • Feeling of chest tightness due to narrowing of the airways (may not always be a true allergic reaction)

Frequency not known: cannot be estimated from the available data.

  • Patients with severe kidney impairment and at higher doses may experience side effects known for intravenous administration
  • Confusion
  • Psychotic disorder
  • Visual disturbance
  • Dizziness

If you experience any of these effects, inform your doctor immediately.

Other possible side effects

Very common: may affect more than 1 in 10 people.

  • Sores in the mouth or throat
  • Cough
  • Breathing difficulties
  • Wheezing
  • Worsening of lung function test results
  • Transient absence of spontaneous breathing

If any of these problems affect you severely, inform your doctor.

Frequency not known: cannot be estimated from the available data.

  • Subjective skin sensations
  • Speech disorder
  • Dizziness
  • Kidney failure

Other possible side effects include thrush in the mouth or throat.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) https://www.notificaram.es

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Colfinair

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton or vial label after EXP. The expiry date is the last day of the month indicated.

Do not store above 25°C.

Keep the vial in the outer carton to protect it from light.

Colfinair solution for inhalation by nebulizer should be used immediately after preparation. If this is not possible, a Colfinair solution should be stored in the refrigerator (2°C - 8°C) and not more than 24 hours.

If not used immediately, storage conditions and times are the responsibility of the user.

Any leftover solution should be discarded.

For single use only.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

Composition of Colfinair

  • The active substance is colistimethate sodium.
  • Each 10 ml vial contains 2 million UI, which is equivalent to approximately 160 mg of colistimethate sodium.

Appearance and packaging of the product

Colfinair is a powder for solution for inhalation by nebulizer.

2 million UI/vial:

White powder in a 10 ml colorless glass vial with a lavender cap.

Also available:

1 million UI/vial:

White powder in a 10 ml colorless glass vial with a red cap.

The product is available in the following pack sizes:

Carton box containing:

  • 8 carton boxes of 7 vials each (56 vials),
  • 2 solution packs for inhalation of NaCl 0.9% with 30 ampoules of 4 ml each (60 ampoules), and a handheld nebulizer eFlowrapid.

Marketing authorization holder and manufacturer

PARI Pharma GmbH

Moosstrasse 3

82319 Starnberg

Germany

Tel.: +49 (0) 89/74 28 46 – 10

You can request more information about this medicine by contacting the local representative of the marketing authorization holder:

PARI Pharma Iberia S.L.

Miguel Yuste 17, 4th floor C.

28037 Madrid

This medicine is authorized in the Member States of the European Economic Area under the following names:

GermanyColiFin 2 Millionen. I.E. Pulver zur Herstellung einer Lösung für einen Vernebler

NetherlandsColiFin PARI 2.000.000 IE Poeder voor verneveloplossing

AustriaColiFin 2 Mio. I. E. Pulver zur Herstellung einer Lösung für einen Vernebler

SpainColfinair 2 million UI powder for solution for inhalation by nebulizer

ItalyColfinair 2.000.000 U Polvere per soluzione per nebulizzatore

Date of last revision of this leaflet: 05/2022

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION

Discuss questions about COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION?
COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION?
The active ingredient in COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION is colistin. This information helps identify medicines with the same composition but different brand names.
Who manufactures COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION?
COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION is manufactured by Pari Pharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to COLFINAIR 2 MILLION IU POWDER FOR SOLUTION FOR NEBULIZER INHALATION?
Other medicines with the same active substance (colistin) include COLFINAIR 1 Million IU Powder for Solution for Nebulizer Inhalation, SODIUM COLISTIMETHATE ACCORD 1 Million IU POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, SODIUM COLISTIMETHATE ACCORD 2 Million IU POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media